Home › Trial NCT06236425
TBio-4101 and Pembro wi/ or w/o Chemo in Recurrent/Metastatic HNSCC
- Trial IDNCT06236425
- StatusCompleted
- PhasePhase 1
- Study typeInterventional
- SponsorH. Lee Moffitt Cancer Center and Research Institute
- Enrollment7
- Start date2024-03-14
- ConditionsSquamous Cell Carcinoma of Head and Neck · Metastatic Squamous Cell Carcinoma
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.